Controlled pupil dilation for diagnostic and treatment of visual anomalies
OwnerRick Lewisinventor
Life of this patent
Estimating the term…
Abstract
Methods and compositions are disclosed for topically applying an ophthalmic solution to the eye to at least temporarily reduce the effects of various visual anomalies. The solution contains a therapeutically effective amount of one or more pupil dilating agents that generate a moderate amount of dilation in order to relieve symptoms such as vitreous floaters. Moreover, the composition may be topically applied in approximately a one drop dose, which may be instilled on an as needed basis depending on the concentration and rate of release of one or more of the following or similar dilating agents: naphazoline, ephedrine, naphazoline HCl, phenylephrine HCl, epinephrine and/or dipivefrin.
Claims21
1-29. (canceled)
A method of prescribing a medication for treating visual anomalies of a patient's eye;
- comprising:
- administering a baseline dosage of a dilating agent topically to the eye;
- measuring the dilation of a the patient's pupil;
- comparing the measured dilation against a desired dilation range;
- and
- changing the dosage until the measured dilation is within the desired range;
- wherein the desired dilation range is configured to reduce the effect of said visual anomalies.
A method for treating visual anomalies of a patient's eye;
- comprising:
- administering a baseline dosage of a dilating agent topically to the eye;
- measuring the dilation of a the patient's pupil;
- comparing the measured dilation against a desired dilation range;
- and
- incrementally increasing the dosage until the measured dilation is within the desired range;
- wherein the desired dilation range is configured to reduce the perception of vitreous floaters.
A method for treating visual anomalies of a patient's eye;
- comprising:
- administering a baseline dosage of a dilating agent topically to the eye;
- measuring the diameter of a the patient's pupil;
- comparing the measured diameter against a desired diameter range;
- and
- incrementally increasing the dosage until the measured diameter is within the desired range;
- wherein the desired diameter range results in a reduction the perception of vitreous floaters.
Dependencies are inferred from the claim text.